GLENMARK
Invest with MTF
Invest Now
Invest in Glenmark Pharmaceuticals with 3.37X leverage
Performance
- Low
- ₹1,957
- High
- ₹1,988
- 52 Week Low
- ₹1,276
- 52 Week High
- ₹2,285
- Open Price₹1,964
- Previous Close₹1,974
- Volume420,804
Investment Returns
- Over 1 Month + 6.67%
- Over 3 Month -1.14%
- Over 6 Month + 30.1%
- Over 1 Year + 27.09%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 55
- PEG Ratio
- 0.3
- Market Cap Cr
- 55,543
- P/B Ratio
- Average True Range
- 44.97
- EPS
- 89.11
- Dividend Yield
- 0.3
- MACD Signal
- 10.53
- RSI
- 62.05
- MFI
- 57.53
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,968.20
-5.6
(-0.28%)
- Bearish Moving Average 1
- Bullish Moving Average 15
- 20 Day
- ₹1,915.13
- 50 Day
- ₹1,910.89
- 100 Day
- ₹1,889.16
- 200 Day
- ₹1,789.46
Resistance and Support
1971.07
- R3 2,016.13
- R2 2,002.07
- R1 1,985.13
- S1 1,954.13
- S2 1,940.07
- S3 1,923.13
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹1,968 As on 05 December, 2025 | 21:03
The Market Cap of Glenmark Pharmaceuticals is ₹55542.8 Cr As on 05 December, 2025 | 21:03
The P/E ratio of Glenmark Pharmaceuticals is 55 As on 05 December, 2025 | 21:03
The PB ratio of Glenmark Pharmaceuticals is 6.3 As on 05 December, 2025 | 21:03
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.